• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆汁酸加剧 SHRSP5/Dmcr 大鼠模型的非酒精性脂肪性肝炎和心血管疾病。

Bile acids aggravate nonalcoholic steatohepatitis and cardiovascular disease in SHRSP5/Dmcr rat model.

机构信息

Department of Medical Technology, Graduate School of Health Sciences, Okayama University, 2-5-1, Shikata-cho, Kita-ku, Okayama-shi, Okayama 700-8558, Japan.

Department of Medical Technology, Faculty of Health Sciences, Okayama University, 2-5-1, Shikata-cho, Kita-ku, Okayama-shi, Okayama 700-8558, Japan.

出版信息

Exp Mol Pathol. 2020 Jun;114:104437. doi: 10.1016/j.yexmp.2020.104437. Epub 2020 Apr 1.

DOI:10.1016/j.yexmp.2020.104437
PMID:32246926
Abstract

BACKGROUND AND AIMS

Nonalcoholic steatohepatitis (NASH) is linked to an increased risk of cardiovascular disease, regardless of the risk factors in metabolic syndrome. However, the intermediary factors between NASH and cardiovascular disease are still unknown. A previous study revealed that serum and hepatic bile acid (BA) levels are increased in some NASH patients. We aimed to examine whether NASH and cardiovascular disease were aggravated by BA using an animal model.

METHOD AND RESULTS

From 10 to 18 weeks of age, SHRSP5/Dmcr rats divided into 3 groups were fed 3 types of high-fat and high-cholesterol (HFC) diets which were changed in the cholic acid (CA) concentration (0%, 2%, or 4%). The nitro oxide synthase inhibition (L-NAME) was administered intraperitoneally from 16 to 18 weeks of age. The 4% CA groups showed the worst LV dysfunction and myocardial fibrosis, and demonstrated severe hepatic fibrosis and lipid depositions. In addition, a large amount of lipid accumulation was observed in the aortas of the 4% CA group, and NFκB and VCAM-1 gene expression levels were increased. These findings were not seen in the 0% CA group.

CONCLUSION

In the SHRSP5/Dmcr rat model, NASH and cardiovascular disease were aggravated with increasing BAs concentrations in an HFC diet.

摘要

背景与目的

非酒精性脂肪性肝炎(NASH)与心血管疾病风险增加相关,而不论代谢综合征中的危险因素如何。然而,NASH 与心血管疾病之间的中介因素仍不清楚。先前的一项研究表明,一些 NASH 患者的血清和肝胆汁酸(BA)水平升高。我们旨在使用动物模型检查 NASH 和心血管疾病是否因 BA 而加重。

方法和结果

从 10 至 18 周龄起,将 SHRSP5/Dmcr 大鼠分为 3 组,分别给予 3 种不同高胆固醇高脂肪(HFC)饮食,其中胆酸(CA)浓度分别为 0%、2%或 4%。从 16 至 18 周龄起,通过腹腔内注射给予一氧化氮合酶抑制剂(L-NAME)。4%CA 组表现出最差的 LV 功能障碍和心肌纤维化,并表现出严重的肝纤维化和脂质沉积。此外,在 4%CA 组的主动脉中观察到大量脂质堆积,NFκB 和 VCAM-1 基因表达水平增加。在 0%CA 组中未观察到这些发现。

结论

在 SHRSP5/Dmcr 大鼠模型中,HFC 饮食中 BA 浓度的增加加重了 NASH 和心血管疾病。

相似文献

1
Bile acids aggravate nonalcoholic steatohepatitis and cardiovascular disease in SHRSP5/Dmcr rat model.胆汁酸加剧 SHRSP5/Dmcr 大鼠模型的非酒精性脂肪性肝炎和心血管疾病。
Exp Mol Pathol. 2020 Jun;114:104437. doi: 10.1016/j.yexmp.2020.104437. Epub 2020 Apr 1.
2
Non-alcoholic steatohepatitis aggravates nitric oxide synthase inhibition-induced arteriosclerosis in SHRSP5/Dmcr rat model.非酒精性脂肪性肝炎加重了SHRSP5/Dmcr大鼠模型中一氧化氮合酶抑制诱导的动脉硬化。
Int J Exp Pathol. 2018 Dec;99(6):282-294. doi: 10.1111/iep.12301. Epub 2019 Jan 24.
3
A High-Fat and High-Cholesterol Diet Induces Cardiac Fibrosis, Vascular Endothelial, and Left Ventricular Diastolic Dysfunction in SHRSP5/Dmcr Rats.高脂肪高胆固醇饮食可诱导 SHRSP5/Dmcr 大鼠心肌纤维化、血管内皮和左室舒张功能障碍。
J Atheroscler Thromb. 2018 May 1;25(5):439-453. doi: 10.5551/jat.40956. Epub 2017 Nov 22.
4
Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet.高脂高胆固醇饮食诱导的实验性非酒精性脂肪性肝炎模型SHRSP5/Dmcr中肝脏病变的病理特征及形态计量分析
Int J Exp Pathol. 2016 Feb;97(1):75-85. doi: 10.1111/iep.12169. Epub 2016 Mar 31.
5
Increased Glycine-conjugated and Unconjugated Bile Acid Levels Associated with Aggravation of Nonalcoholic Steatohepatitis and Cardiovascular Disease in SHRSP5/Dmcr Rat.与SHRSP5/Dmcr大鼠非酒精性脂肪性肝炎和心血管疾病加重相关的甘氨酸结合型和非结合型胆汁酸水平升高
Acta Med Okayama. 2023 Feb;77(1):29-36. doi: 10.18926/AMO/64358.
6
SHRSP5/Dmcr rats fed a high-fat and high-cholesterol diet develop disease-induced sarcopenia as nonalcoholic steatohepatitis progresses.SHRSP5/Dmcr 大鼠在高脂肪和高胆固醇饮食喂养下,随着非酒精性脂肪性肝炎的进展,会发展出疾病诱导性的肌肉减少症。
Ann Anat. 2023 Aug;249:152104. doi: 10.1016/j.aanat.2023.152104. Epub 2023 May 18.
7
Bile acid detoxifying enzymes limit susceptibility to liver fibrosis in female SHRSP5/Dmcr rats fed with a high-fat-cholesterol diet.胆汁酸解毒酶可降低高脂胆固醇饮食喂养的雌性SHRSP5/Dmcr大鼠发生肝纤维化的易感性。
PLoS One. 2018 Feb 13;13(2):e0192863. doi: 10.1371/journal.pone.0192863. eCollection 2018.
8
Suppression of nitric oxide synthase aggravates non-alcoholic steatohepatitis and atherosclerosis in SHRSP5/Dmcr rat via acceleration of abnormal lipid metabolism.抑制一氧化氮合酶通过加速异常脂质代谢加重 SHRSP5/Dmcr 大鼠非酒精性脂肪性肝炎和动脉粥样硬化。
Pharmacol Rep. 2022 Aug;74(4):669-683. doi: 10.1007/s43440-022-00380-1. Epub 2022 Jul 12.
9
Importance of detoxifying enzymes in differentiating fibrotic development between SHRSP5/Dmcr and SHRSP rats.解毒酶在区分SHRSP5/Dmcr大鼠和SHRSP大鼠纤维化发展中的重要性。
Environ Health Prev Med. 2016 Sep;21(5):368-381. doi: 10.1007/s12199-016-0539-x. Epub 2016 May 21.
10
Therapeutic effect of ouabagenin, a novel liver X receptor agonist, on atherosclerosis in nonalcoholic steatohepatitis in SHRSP5/Dmcr rat model.新型肝 X 受体激动剂沙库巴曲缬沙坦钠对 SHRSP5/Dmcr 大鼠非酒精性脂肪性肝炎相关动脉粥样硬化的治疗作用。
Can J Physiol Pharmacol. 2023 Sep 1;101(9):455-465. doi: 10.1139/cjpp-2022-0532. Epub 2023 May 24.

引用本文的文献

1
prevents high-fat diet-induced non-alcoholic fatty liver disease in rats by inhibiting expression the TLR4/MyD88 and the phosphorylation of NF-κB.通过抑制 TLR4/MyD88 的表达和 NF-κB 的磷酸化,防止高脂肪饮食诱导的大鼠非酒精性脂肪性肝病。
Pharm Biol. 2022 Dec;60(1):1960-1968. doi: 10.1080/13880209.2022.2127153.
2
Suppression of nitric oxide synthase aggravates non-alcoholic steatohepatitis and atherosclerosis in SHRSP5/Dmcr rat via acceleration of abnormal lipid metabolism.抑制一氧化氮合酶通过加速异常脂质代谢加重 SHRSP5/Dmcr 大鼠非酒精性脂肪性肝炎和动脉粥样硬化。
Pharmacol Rep. 2022 Aug;74(4):669-683. doi: 10.1007/s43440-022-00380-1. Epub 2022 Jul 12.
3
Farnesoid X receptor (FXR) agonists induce hepatocellular apoptosis and impair hepatic functions via FXR/SHP pathway.
法尼酯X受体(FXR)激动剂通过FXR/SHP途径诱导肝细胞凋亡并损害肝功能。
Arch Toxicol. 2022 Jun;96(6):1829-1843. doi: 10.1007/s00204-022-03266-6. Epub 2022 Mar 10.
4
Circulating bile acids concentration is predictive of coronary artery disease in human.循环胆汁酸浓度可预测人类的冠状动脉疾病。
Sci Rep. 2021 Nov 22;11(1):22661. doi: 10.1038/s41598-021-02144-y.
5
Activation of the gut microbiota-kynurenine-liver axis contributes to the development of nonalcoholic hepatic steatosis in nondiabetic adults.肠道微生物群-犬尿氨酸-肝脏轴的激活有助于非糖尿病成人非酒精性肝脂肪变性的发展。
Aging (Albany NY). 2021 Sep 2;13(17):21309-21324. doi: 10.18632/aging.203460.